$BCRX 3/A SEC Filings

Filed On	Filing
24 Sep 2009	Form 3/A: Babu Yarlagadda S, VP Drug Discovery Holds 69,362 shares of Common Stock
06 Jan 2009	Form 3/A: Mills Mike, Principal Accounting Officer Holds 798 shares of Common Stock
06 Jan 2009	Form 3/A: Mills Mike, Principal Accounting Officer No securities owned
18 May 2004	Form 3/A: Higgins John L, Director Holds 0 shares of None
10 Mar 2004	Form 3/A: Gordon Carl L, Director Holds 0 shares of NONE

Comments